A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab

Clinical trial NCT06225635 · COMPLETED

Trial details

NCT number: NCT06225635
Sponsor: Shin Poong Pharmaceutical Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hyperlipidemias

Start date: 2022-01-01
Primary completion: 2022-03-07
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.